Form 4: Perrigo Executive Alison Ives Reports Stock Transactions
SEC Form 4 Filing
EVP & Chief Scientific Officer of Perrigo, Alison Ives, reports acquisition and disposal of ordinary shares and restricted stock units on March 5, 2024.
Summary
- Alison Ives, EVP & Chief Scientific Officer of Perrigo Co. plc, reported transactions involving ordinary shares and restricted stock units on March 5, 2024.
- The transactions included the acquisition of 4,188 ordinary shares through the exercise of restricted stock units and open market purchases.
- Ives also disposed of 1,262 ordinary shares to cover tax obligations related to the vesting of restricted stock units.
- Following these transactions, Ives beneficially owns 15,372 ordinary shares.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing reporting stock transactions. It doesn't inherently convey positive or negative sentiment.
Industry Context
This filing is a routine disclosure of stock transactions by a company executive, which is common practice for publicly traded companies. It provides transparency into the trading activities of insiders.
Stakeholder Impact
- The transactions may have a minor impact on shareholders by slightly altering the ownership structure of the company.
Key Dates
| Date | Description |
|---|---|
| 03/05/2024 | Date of transactions involving ordinary shares and restricted stock units. |
| 03/07/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.